Excision of a subcutaneous soft tissue tumor of the abdominal wall measuring less than 3 cm, including the tumor plus the margin required for complete removal.
Verified May 8, 2026 · 5 sources ↓
- Medicare
- $517.38
- Total RVUs
- 15.49
- Global, days
- 90
- Region
- General
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 5 cited references ↓
- Intraoperative measurement of tumor plus required margin (greatest diameter, recorded in cm at time of excision)
- Explicit documentation of tissue depth — subcutaneous vs. subfascial — to justify 22902 over 22900/22901
- Pathology report or operative note identifying lesion type (e.g., lipoma, hemangioma, fibroma)
- Operative note stating the surgical approach and confirmation of complete excision
- Indication for excision with corresponding ICD-10 diagnosis code supporting medical necessity
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 5 cited references ↓
CPT 22902 covers surgical removal of a subcutaneous (above the fascia) soft tissue tumor of the abdominal wall when the specimen — measured as the greatest diameter of the tumor plus the narrowest margin required for complete excision — is less than 3 cm. That measurement is made at the time of excision, not from a post-fixation pathology specimen. Code selection between 22902 and its companion code 22903 (≥3 cm) hinges entirely on that intraoperative measurement, so the operative note must document it explicitly.
The 22902/22903 family lives in the musculoskeletal system subsection, not the general surgery section. Subfascial (intramuscular) abdominal wall tumors are a separate family — 22900 (<5 cm) and 22901 (≥5 cm). Mixing subcutaneous and subfascial codes is a common upcoding audit flag, so depth of dissection must be clearly stated in the operative note.
The 90-day global period applies. Any E/M or procedure during that window for a related indication requires modifier 24 or 79 as appropriate. Site-of-service matters here: HOPD and ASC payments differ substantially — see the Site of Service comparison table on this page.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 4.31 |
| Practice expense RVU | 10.11 |
| Malpractice RVU | 1.07 |
| Total RVU | 15.49 |
| Medicare national rate | $517.38 |
| Global period | 90 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $517.38 |
HOPD (APC 5072) Hospital outpatient department | $1,687.37 |
ASC (PI G2) Ambulatory surgical center (freestanding) | $742.04 |
Common denial reasons
The recurring reasons claims for CPT 22902 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Tumor size not documented in the operative note — payer defaults to the lower-value code or denies outright
- Depth ambiguity: subcutaneous vs. subfascial not specified, triggering a medical necessity review or downcoding to an integumentary excision code
- Procedure billed during the global period of a prior related surgery without modifier 79 or 24
- Code mismatch between the subcutaneous family (22902/22903) and the subfascial family (22900/22901) based on operative documentation
- Missing or mismatched ICD-10 diagnosis code — benign vs. malignant lesion coding inconsistent with pathology
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01How is the size threshold for 22902 vs. 22903 measured?
02What is the difference between 22902 and 22900?
03Can 22902 be billed with wound closure codes?
04What modifiers apply when 22902 is performed bilaterally or with another procedure the same day?
05Does the 90-day global period affect post-op visits or related procedures?
06Is 22902 appropriate for hemangioma or lipoma excision from the abdominal wall?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01facs.orghttps://www.facs.org/for-medical-professionals/news-publications/news-and-articles/bulletin/2021/10/reporting-excision-of-soft-tissue-tumor-codes/
- 02mdclarity.comhttps://www.mdclarity.com/cpt-code/22902
- 03aapc.comhttps://www.aapc.com/codes/cpt-codes/22902
- 04findacode.comhttps://www.findacode.com/cpt/22902-cpt-code.html
- 05CMS Physician Fee Schedule 2026
Mira AI Scribe
Mira's AI scribe captures the intraoperative tumor-plus-margin measurement, tissue depth (subcutaneous vs. subfascial), lesion type, and confirmation of complete excision directly from dictation. This prevents the most common 22902 denial: an operative note that states tumor size without margin, or fails to distinguish subcutaneous from subfascial depth — both of which trigger downcoding or medical necessity reviews.
See how Mira captures CPT 22902 documentation